eosinophil

(redirected from Eosinophils)
Also found in: Thesaurus, Medical, Encyclopedia.

e·o·sin·o·phil

 (ē′ə-sĭn′ə-fĭl′) also e·o·sin·o·phile (-fīl′)
n.
A white blood cell that functions in the immune response by releasing enzymes that can kill parasites and other pathogens. Eosinophils are found chiefly in connective tissue and contain granules that are stained by eosin or other acid dyes.
adj.
Eosinophilic.

eosinophil

(ˌiːəʊˈsɪnəˌfɪl) or

eosinophile

n
(Physiology) a leucocyte with a multilobed nucleus and coarse granular cytoplasm that stains readily with acidic dyes such as eosin
ˌeoˌsinoˈphilic, eosinophilous adj

e•o•sin•o•phil

(ˌi əˈsɪn ə fɪl)

also e•o•sin•o•phile

(-ˌfaɪl)

n.
1. any biological substance that stains when exposed to eosin.
2. a white blood cell that contains eosinophilic granules.
adj.

eosinophil

A type of white blood cell that takes up the red dye eosin.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.eosinophil - a leukocyte readily stained with eosineosinophil - a leukocyte readily stained with eosin
leucocyte, leukocyte, WBC, white blood cell, white blood corpuscle, white cell, white corpuscle - blood cells that engulf and digest bacteria and fungi; an important part of the body's defense system
Translations
eosinofil

e·o·sin·o·phil

, eosinophile
n. eosinófilo, célula granulocítica que acepta fácilmente la acción colorante de la eosina.

eosinophil

n eosinófilo
References in periodicals archive ?
OB) (the "Company") reports that post-infection treatment with its optimized FluCide[TM] drug candidates resulted in significant reduction in lung tissue presence of leukocytes, and in particular, that of eosinophils in a lethal influenza infection animal model.
In the last decade several studies, both in vitro and in vivo, have revealed a pivotal role for eosinophils and their granule content in immunomodulation, host defence and in pathology of eosinophil-associated diseases, such as allergy and asthma.
Many have thought that targeting the Th2 pathway in asthma would limit benefit to a subset of asthmatics, such as those with high eosinophils.
Eosinophils are the principal effector cells involved in the pathogenesis of allergic inflammation.
Nucala is the first and only approved biologic therapy that targets interleukin-5 (IL-5), which plays an important role in regulating the function of eosinophils, an inflammatory cell known to be important in asthma.
In a sub-set of severe asthma patients, the over-production of eosinophils (a type of white blood cell) is known to cause inflammation in the lungs that can affect the airways, limiting breathing and increasing the frequency of asthma attacks.
They found 20 per cent of those with facial fuzz had clusters of white blood cells called eosinophils - part of the body's natural defence mechanism - in their noses.
They found 20% of those with facial fuzz had clusters of white blood cells called eosinophils - part of the body's natural defence mechanism - in their noses.
Reslizumab is a humanised anti-interleukin-5 (IL-5) monoclonal antibody (mAb) for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, despite an inhaled corticosteroid (ICS)-based regimen.
The clearest example is seen in the differences between eosinophilic and neutrophilic polyps; some patients have more eosinophils than neutrophils, and others have more neutrophils than eosinophils.
Eosinophils play an important role in the immune system, helping to fight off certain types of infections and parasites.
a CVM post-doctoral fellow and the study's lead author, and colleagues have identified factors that up-regulate the ORMDL3 gene in specific white blood cells such as eosinophils during allergic asthma.